Literature DB >> 17845935

Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt.

Richard D Fremont1, Aaron P Milstone, Richard W Light, Mathew Ninan.   

Abstract

Chylous effusions are a well-described complication of lymphangioleiomyomatosis (LAM) in both pre- and post-transplant patients. Chylous effusions can cause significant morbidity among patients and most treatment modalities have limitations to complete success. We describe the use of a pleurovenous shunt to treat a refractory chylous effusion in a patient after lung transplant for LAM. After shunt placement, the patient had complete resolution of the chylous effusion and subsequent discharge home after a prolonged hospitalization. The use of a pleurovenous shunt for refractory chylous effusions is a viable option after conventional therapy fails.

Entities:  

Mesh:

Year:  2007        PMID: 17845935     DOI: 10.1016/j.healun.2007.07.008

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Acute constrictive pericarditis after lung transplantation for lymphangioleiomyomatosis.

Authors:  Martha E Billings; Michael Mulligan; Ganesh Raghu
Journal:  J Heart Lung Transplant       Date:  2008-12-12       Impact factor: 10.247

Review 2.  Nutritional Requirements of Lung Transplant Recipients: Challenges and Considerations.

Authors:  Valerie Jomphe; Larry C Lands; Genevieve Mailhot
Journal:  Nutrients       Date:  2018-06-19       Impact factor: 5.717

3.  Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.

Authors:  Jana Pospiskova; Lukas Smolej; David Belada; Martin Simkovic; Monika Motyckova; Alice Sykorova; Pavla Stepankova; Pavel Zak
Journal:  Orphanet J Rare Dis       Date:  2019-01-09       Impact factor: 4.123

4.  Refractory chylous effusions in lymphangioleiomyomatosis patient post lung transplant.

Authors:  Samuel Jacob; Mojahid Ali; Magdy M El-Sayed Ahmed; Maxim Itkin; Tathagat Narula; Si Pham; David Erasmus
Journal:  SAGE Open Med Case Rep       Date:  2020-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.